SlideShare ist ein Scribd-Unternehmen logo
1 von 10
Diagnostic/Medical Devices Track
Value of Diagnostic Information (VODI)
from Concept to Reality
Socio-economic aspects of
Value of Knowing
Bernarda Zamora
Office of Health Economics
Motivation
Concern that traditional health technology
assessment (HTA) does not appropriately
recognize or reward the value of diagnostics
Need to broaden the concept of diagnostics
beyond companion diagnostics:
“Complementary diagnostics”
Diagnostics provide value to patients beyond
health gain and cost-saving: they can reduce
uncertainty about benefit:
“Value of knowing”
OHE/EPEMED White Paper
To identify key issues facing the HTA
of complementary diagnostics in
Europe
To provide coherent and consistent
terminology for the definition of
diagnostics and the elements of value
To define options for addressing
challenges and barriers
To recommend approaches for dealing with them
Definition of Complementary
Diagnostics
Steps towards implementation
ISPOR Initiative on US Value
Assessment Frameworks
ISPOR Initiative on US Value
Assessment Frameworks
Recommendation 3.1: Apply cost-
effectiveness analysis to inform public
and private coverage and
reimbursement decision making
Recommendation 3.2: Support additional
research that enhances the
applicability, scope, and relevance of
cost-effectiveness analysis for decision
making
CONCLUSIONS
Application of Extended CEA
Thank you
Email: bzamora@ohe.org
Website: www.ohe.org • Blog: http://news.ohe.org/

Weitere ähnliche Inhalte

Was ist angesagt?

The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyjangeissler
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseasesjangeissler
 
Training medical policy program final version 3
Training medical policy program final version 3Training medical policy program final version 3
Training medical policy program final version 3Emily Barton
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...Office of Health Economics
 
The role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicineThe role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicinejangeissler
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Office of Health Economics
 
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...Office of Health Economics
 
Systematic Review of CoPs in surgery
Systematic Review of CoPs in surgerySystematic Review of CoPs in surgery
Systematic Review of CoPs in surgeryegoubanova
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardOffice of Health Economics
 
Medical research:-rebuilt,-retooled -and -rebooted ppt
Medical  research:-rebuilt,-retooled -and -rebooted pptMedical  research:-rebuilt,-retooled -and -rebooted ppt
Medical research:-rebuilt,-retooled -and -rebooted pptPuja Roy
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology AssessmentEUPATI
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisionsEUPATI
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Office of Health Economics
 
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...Office of Health Economics
 

Was ist angesagt? (20)

The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
Training medical policy program final version 3
Training medical policy program final version 3Training medical policy program final version 3
Training medical policy program final version 3
 
HSCIC: Patient Reported Outcome Measures (PROMS)
HSCIC: Patient Reported Outcome Measures (PROMS)HSCIC: Patient Reported Outcome Measures (PROMS)
HSCIC: Patient Reported Outcome Measures (PROMS)
 
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
 
The role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicineThe role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicine
 
Real World Evidence Initiative Report
Real World Evidence Initiative ReportReal World Evidence Initiative Report
Real World Evidence Initiative Report
 
0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
 
Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...Data Governance for Real-World Evidence: Cross-country differences and recomm...
Data Governance for Real-World Evidence: Cross-country differences and recomm...
 
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
 
Systematic Review of CoPs in surgery
Systematic Review of CoPs in surgerySystematic Review of CoPs in surgery
Systematic Review of CoPs in surgery
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
 
Ispor measuring access_pon_nd
Ispor measuring access_pon_ndIspor measuring access_pon_nd
Ispor measuring access_pon_nd
 
Medical research:-rebuilt,-retooled -and -rebooted ppt
Medical  research:-rebuilt,-retooled -and -rebooted pptMedical  research:-rebuilt,-retooled -and -rebooted ppt
Medical research:-rebuilt,-retooled -and -rebooted ppt
 
Health Technology Assessment
Health Technology AssessmentHealth Technology Assessment
Health Technology Assessment
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisions
 
Jornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas BereczkyJornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas Bereczky
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...
DOES SOCIETY WISH TO PLACE GREATER WEIGHT ON A UNIT OF HEALTH GAIN FOR END OF...
 

Ähnlich wie Value of Diagnostic Information (VODI) from Concept to Reality. Socio-economic aspects of Value of Knowing

EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine PayneEuroBioForum
 
Minute Interview: Value Based Procurement
Minute Interview: Value Based ProcurementMinute Interview: Value Based Procurement
Minute Interview: Value Based ProcurementThe MarkeTech Group
 
Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Office of Health Economics
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overviewshashi sinha
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHAnna Kotzeva
 
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsPersonalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsOffice of Health Economics
 
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsPersonalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsOffice of Health Economics
 
Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15CADTH Symposium
 
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applicationsMAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applicationsHTAi Bilbao 2012
 
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAPBIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAPNathan White, CPC
 
BIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studiesBIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studiesNathan White, CPC
 
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HxRefactored
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed MarketsExL Pharma
 
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...3GDR
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
hsns09:The Scottish telecare development programme:the evaluation - Sophie Beale
hsns09:The Scottish telecare development programme:the evaluation - Sophie Bealehsns09:The Scottish telecare development programme:the evaluation - Sophie Beale
hsns09:The Scottish telecare development programme:the evaluation - Sophie BealeIriss
 
06 Am09 Presentations Gutman
06 Am09 Presentations   Gutman06 Am09 Presentations   Gutman
06 Am09 Presentations GutmanSimon Prince
 
What is a good app_Trappenburg 2.0
What is a good app_Trappenburg 2.0What is a good app_Trappenburg 2.0
What is a good app_Trappenburg 2.0Jaap Trappenburg PhD
 
Health economic evaluation for the NHS workshop
Health economic evaluation for the NHS workshopHealth economic evaluation for the NHS workshop
Health economic evaluation for the NHS workshopInnovation Agency
 

Ähnlich wie Value of Diagnostic Information (VODI) from Concept to Reality. Socio-economic aspects of Value of Knowing (20)

EuroBioForum 2013 - Day 1 | Katherine Payne
 EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
 
Minute Interview: Value Based Procurement
Minute Interview: Value Based ProcurementMinute Interview: Value Based Procurement
Minute Interview: Value Based Procurement
 
Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making Dimensions of value, assessment, and decision making
Dimensions of value, assessment, and decision making
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTH
 
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsPersonalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
 
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA ConsiderationsPersonalised Medicine in the EU— Evolving Landscape and New HTA Considerations
Personalised Medicine in the EU— Evolving Landscape and New HTA Considerations
 
Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d7 presentation 2015 14 apr15
 
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applicationsMAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applications
 
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAPBIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
BIOTECH 2011 A POWERFUL PAYER: PRICING & REIMBURSEMENT ROADMAP
 
BIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studiesBIOTECH 2011 NJ/DE/PA Case studies
BIOTECH 2011 NJ/DE/PA Case studies
 
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
 
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's  2nd Pharmaceutical Managed MarketsHighlights from ExL Pharma's  2nd Pharmaceutical Managed Markets
Highlights from ExL Pharma's 2nd Pharmaceutical Managed Markets
 
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
hsns09:The Scottish telecare development programme:the evaluation - Sophie Beale
hsns09:The Scottish telecare development programme:the evaluation - Sophie Bealehsns09:The Scottish telecare development programme:the evaluation - Sophie Beale
hsns09:The Scottish telecare development programme:the evaluation - Sophie Beale
 
06 Am09 Presentations Gutman
06 Am09 Presentations   Gutman06 Am09 Presentations   Gutman
06 Am09 Presentations Gutman
 
Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navar...
Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navar...Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navar...
Evidence-Generation in Digital Healthcare: Demonstrating Value. Prakash Navar...
 
What is a good app_Trappenburg 2.0
What is a good app_Trappenburg 2.0What is a good app_Trappenburg 2.0
What is a good app_Trappenburg 2.0
 
Health economic evaluation for the NHS workshop
Health economic evaluation for the NHS workshopHealth economic evaluation for the NHS workshop
Health economic evaluation for the NHS workshop
 

Mehr von Office of Health Economics

OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOffice of Health Economics
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowseOffice of Health Economics
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...Office of Health Economics
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...Office of Health Economics
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isOffice of Health Economics
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Office of Health Economics
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?Office of Health Economics
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleOffice of Health Economics
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeOffice of Health Economics
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Office of Health Economics
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMROffice of Health Economics
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Office of Health Economics
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandOffice of Health Economics
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Office of Health Economics
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...Office of Health Economics
 

Mehr von Office of Health Economics (20)

Annual lecture
Annual lecture Annual lecture
Annual lecture
 
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
 

Kürzlich hochgeladen

Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Doveagatadrynko
 
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near MeBook Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Menarwatsonia7
 
Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949ps5894268
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarCareLineLive
 
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Service
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts ServiceCall Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Service
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Servicenarwatsonia7
 
Call Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any TimeCall Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any Timedelhimodelshub1
 
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...narwatsonia7
 
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service GoaRussian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goanarwatsonia7
 
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call Girls
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call GirlsBook Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call Girls
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call GirlsCall Girls Noida
 
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...ggsonu500
 
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...High Profile Call Girls Chandigarh Aarushi
 
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...soniya singh
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Timedelhimodelshub1
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availablesandeepkumar69420
 

Kürzlich hochgeladen (20)

Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service GuwahatiCall Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
 
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Dove
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near MeBook Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
Book Call Girls in Hosur - 7001305949 | 24x7 Service Available Near Me
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So Far
 
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Service
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts ServiceCall Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Service
Call Girl Service ITPL - [ Cash on Delivery ] Contact 7001305949 Escorts Service
 
Call Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any TimeCall Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any Time
 
Call Girl Lucknow Gauri 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girl Lucknow Gauri 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girl Lucknow Gauri 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girl Lucknow Gauri 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...
Hi,Fi Call Girl In Whitefield - [ Cash on Delivery ] Contact 7001305949 Escor...
 
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service GoaRussian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
 
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call Girls
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call GirlsBook Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call Girls
Book Call Girls in Noida Pick Up Drop With Cash Payment 9711199171 Call Girls
 
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
 
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...
Gurgaon iffco chowk 🔝 Call Girls Service 🔝 ( 8264348440 ) unlimited hard sex ...
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Time
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service available
 

Value of Diagnostic Information (VODI) from Concept to Reality. Socio-economic aspects of Value of Knowing

  • 1.
  • 2. Diagnostic/Medical Devices Track Value of Diagnostic Information (VODI) from Concept to Reality Socio-economic aspects of Value of Knowing Bernarda Zamora Office of Health Economics
  • 3. Motivation Concern that traditional health technology assessment (HTA) does not appropriately recognize or reward the value of diagnostics Need to broaden the concept of diagnostics beyond companion diagnostics: “Complementary diagnostics” Diagnostics provide value to patients beyond health gain and cost-saving: they can reduce uncertainty about benefit: “Value of knowing”
  • 4. OHE/EPEMED White Paper To identify key issues facing the HTA of complementary diagnostics in Europe To provide coherent and consistent terminology for the definition of diagnostics and the elements of value To define options for addressing challenges and barriers To recommend approaches for dealing with them
  • 6.
  • 7. Steps towards implementation ISPOR Initiative on US Value Assessment Frameworks
  • 8. ISPOR Initiative on US Value Assessment Frameworks Recommendation 3.1: Apply cost- effectiveness analysis to inform public and private coverage and reimbursement decision making Recommendation 3.2: Support additional research that enhances the applicability, scope, and relevance of cost-effectiveness analysis for decision making